Status:
COMPLETED
Trial of Mesalamine for the Treatment of Active Microscopic Colitis
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
Paul E. Evans MD
William J. Sandborn MD
Conditions:
Microscopic Colitis
Diarrhea
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
Subjects must be 18 years old and older, have diarrhea and microscopic colitis. Pregnant or nursing females are excluded. They can't have other untreated diarrheal conditions. Subjects will receive me...
Detailed Description
We propose a prospective, randomized trial of mesalamine at 1.2g and 4.8g doses for the treatment of microscopic colitis. Our hypothesis is mesalamine is safe and effective for the treatment of diarrh...
Eligibility Criteria
Inclusion
- Subjects must be 18 years old and older.
- Have diarrhea and microscopic colitis.
- They need to have a colon biopsy done at the Mayo Clinic in Rochester, MN within a year of enrollment.
Exclusion
- None.
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00952952
Start Date
February 1 2007
End Date
November 1 2007
Last Update
May 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905